Rchr
J-GLOBAL ID:202101009523185757   Update date: Nov. 07, 2024

Kato Shinichiro

カトウ シンイチロウ | Kato Shinichiro
Affiliation and department:
Job title: Assistant Professor
Research theme for competitive and other funds  (7):
  • 2023 - 2026 がん薬剤耐性化におけるパーシスター細胞の運命決定機構
  • 2022 - 2025 細胞系譜特異的ながん細胞増殖を制御する長鎖ノンコーディングRNAの機能解析
  • 2021 - 2023 表現型追跡技術が解き明かすがん治療耐性化のシンギュラリティ
  • 2020 - 2023 エピゲノムダイナミクスに基づくがん多様性の新たな理解
  • 2020 - 2022 Elucidation of tumor immune regulatory mechanism by histone methyltransferase G9a and its application as a therapeutic target
Show all
Papers (12):
  • Muran Xiao, Shinji Kondo, Masaki Nomura, Shinichiro Kato, Koutarou Nishimura, Weijia Zang, Yifan Zhang, Tomohiro Akashi, Aaron Viny, Tsukasa Shigehiro, et al. BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state. Nature communications. 2023. 14. 1. 8372-8372
  • Shinichiro Kato, Yuka Maeda, Daisuke Sugiyama, Keisuke Watanabe, Hiroyoshi Nishikawa, Kunihiko Hinohara. The cancer epigenome: Non-cell autonomous player in tumor immunity. Cancer science. 2023. 114. 3. 730-740
  • Satoru Yokoyama, Atsushi Takahashi, Ryota Kikuchi, Soshi Nishibu, Jennifer A Lo, Miroslav Hejna, Wooyoung M Moon, Shinichiro Kato, Yue Zhou, F Stephen Hodi, et al. SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis. Cancer research. 2021. 81. 24. 6131-6141
  • Jennifer Allouche, Inbal Rachmin, Kaustubh Adhikari, Luba M Pardo, Ju Hee Lee, Alicia M McConnell, Shinichiro Kato, Shaohua Fan, Akinori Kawakami, Yusuke Suita, et al. NNT mediates redox-dependent pigmentation via a UVB- and MITF-independent mechanism. Cell. 2021. 184. 16. 4268-4283
  • Lajos V Kemény, Kathleen C Robinson, Andrea L Hermann, Deena M Walker, Susan Regan, Yik Weng Yew, Yi Chun Lai, Nicholas Theodosakis, Phillip D Rivera, Weihua Ding, et al. Vitamin D deficiency exacerbates UV/endorphin and opioid addiction. Science advances. 2021. 7. 24
more...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page